BEAM vs NCLH · rev $32.2M vs P/E 16, rev $4.97B
Beam Therapeutics Inc (BEAM) versus Norwegian Cruise Line Holdings Ltd (NCLH) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Latest reported BEAM revenue for 2026-06-30 was $32.2M. Net income was -$217.0M. Revenue was up 1.5% from 2026-03-31 to 2026-06-30. BEAM currently screens at market cap $2.01B.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
BEAM currently screens at market cap $2.01B. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Not investment advice. Open the BEAM and NCLH stock pages for the full models.
Not investment advice.